Eliem Therapeutics Quarterly Balance Sheets Chart
Quarterly
|
Annual
Eliem Therapeutics Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2024-03-31 | 2023-12-31 |
|---|---|---|
| current assets: | ||
| cash and cash equivalents | 105,031,000 | 93,112,000 |
| short-term marketable securities | 13,686,000 | |
| prepaid expenses and other current assets | 4,192,000 | 3,457,000 |
| total current assets | 109,223,000 | 110,255,000 |
| operating lease right-of-use assets | 111,000 | 199,000 |
| other long-term assets | 15,000 | |
| total assets | 109,334,000 | 110,469,000 |
| liabilities and stockholders’ equity | ||
| current liabilities: | ||
| accounts payable | 85,000 | 66,000 |
| accrued expenses and other current liabilities | 2,640,000 | 2,433,000 |
| operating lease liabilities | 225,000 | 334,000 |
| total current liabilities | 2,950,000 | 2,833,000 |
| operating lease liabilities, net of current portion | 15,000 | |
| other long-term liabilities | 22,000 | |
| total liabilities | 2,950,000 | 2,870,000 |
| commitments and contingencies | ||
| stockholders’ equity | ||
| common stock | 3,000 | 3,000 |
| additional paid-in capital | 264,057,000 | 263,577,000 |
| accumulated other comprehensive loss | -2,000 | |
| accumulated deficit | -157,676,000 | -155,979,000 |
| total stockholders’ equity | 106,384,000 | 107,599,000 |
| total liabilities and stockholders’ equity | 109,334,000 | 110,469,000 |
| assets |
We provide you with 20 years of balance sheets for Eliem Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Eliem Therapeutics. Explore the full financial landscape of Eliem Therapeutics stock with our expertly curated balance sheets.
The information provided in this report about Eliem Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.